how to properly plan and conduct research projects? farahnak assadi, md emeritus professor pediatric...
TRANSCRIPT
![Page 1: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/1.jpg)
How to properly plan and conduct research projects?
Farahnak Assadi, MD
Emeritus Professor
Pediatric Nephrology
![Page 2: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/2.jpg)
©2007 RUSH University Medical Center
1.Turn your ideas into research questions
2. Review the literature
3. Design the study and develop your methods
4. Writing your research proposal
5. Obtain ethical and trust approval
6. Collect and collate the data
7. Analyze the data and interpret the findings
8. Report on the study and the findings
• Decide on an area of research• What is your aim and
hypothesis?• Where do I start?• Libraries• Links to useful websites
• Participant involvement• Statistic issues• Collaboration
• Peer review• Sponsor issues
• Why ethics are so important?• Prepare consent forms• Contact your RD office
• Issues to consider• Data protection and
confidentiality • Data analysis• Interpreting data
• Publishing your research• Future direction
Research Process Flowchart
![Page 3: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/3.jpg)
Turning your ideas into research
• Stay up to date on the area of specific research
• Keep up with the current literature on the area of your research proposal
• Avoid duplicating what is already known• Be creative and develop a new idea
©2007 RUSH University Medical Center
![Page 4: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/4.jpg)
Review the literature
• Where do I start?
- Discuss with your mentor
- Start reading
- Identify the most important gaps in knowledge
and prioritize the unanswered questions about
your research
• Libraries• Links to useful websites
- PubMed, MEDLINE, etc
©2007 RUSH University Medical Center
![Page 5: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/5.jpg)
©2007 RUSH University Medical Center
Review literature (cont’d)
• Isolated persistent asymptomatic hematuria occurs in about 2%-3% in school age children
• It is the most common laboratory finding of renal disease
![Page 6: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/6.jpg)
©2007 RUSH University Medical Center
isolated asymptomatic hematuria
• No proteinuria on dipstick-test• Normal BUN and serum creatinine levels• Negative TB test• Normal serum C3, C4, CH50• Ca/Cr ratio <0.22• Normal renal ultrasound• Negative urine culture
![Page 7: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/7.jpg)
©2007 RUSH University Medical Center
Consider other causes
• Benign hematuria (TGBM disease ) • IgA nephropathy• Alport’s syndrome
• 51%
• 49%• 1.0%
![Page 8: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/8.jpg)
©2007 RUSH University Medical Center
To do the kidney biopsy!
• A policy of recommending renal biopsy for the diagnosis of isolated persistent hematuria would lead to a large number of patients with benign hematuria (51%)
![Page 9: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/9.jpg)
©2007 RUSH University Medical Center
Not to do the kidney biopsy!
• A policy of deferring renal biopsy in all patients until more overt signs of a progressive nephropathy develop may delay the appropriate management of a chronic kidney disease (49%)
![Page 10: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/10.jpg)
©2007 RUSH University Medical Center
To do or not to do biopsy?
![Page 11: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/11.jpg)
©2007 RUSH University Medical Center
Hypothesis
• Inflammation is an important risk factor in the initiation of HTN, CVD, CKD, and stroke in both diabetic and non-diabetic patients
• Microalbuminuria (MA/Cr >30 mg/g) is a sensitive marker of inflammation and a powerful predictor of CKD, particularly in nephropathy due to diabetes
![Page 12: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/12.jpg)
©2007 RUSH University Medical Center
Spesific aim
• To investigate the value of urinary microalbumin excretion in predicting glomerular abnormalities in children with isolated persistent hematuria
![Page 13: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/13.jpg)
Design the study and develop a method
• Decide on a general area of interest• Why does this area interest you?• What is your aim?• What is you hypothesis?• Is your idea novel?• How will patients benefit from your research?• Consult colleagues and other researchers
©2007 RUSH University Medical Center
![Page 14: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/14.jpg)
Obtain ethical and trust approval
• Why ethics are so important• Applying to a research ethics committee• Prepare consent forms
- Prepare information sheet checklists
- Prepare consent form
• Contact your RD office
©2007 RUSH University Medical Center
![Page 15: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/15.jpg)
Collect and collate the data
• Issues to consider - Beware of biases
- Seek statistical advice if necessary
- Researchers must bear the day-to-day responsibility
for the conduct of research
• Data protection and confidentiality
- Identities should be avoided by use of codes
-
©2007 RUSH University Medical Center
![Page 16: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/16.jpg)
Analyze and interpret the data
• Quantitative data analysis
- Identifying a data entry and analysis
manager (SPSS)
- Coding data
- interpreting data
• Qualitative data analysis
- Familiarization with the data
- Development of provisional categories
- Development of theory and incorporation of pre-
existing knowledge
©2007 RUSH University Medical Center
![Page 17: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/17.jpg)
©2007 RUSH University Medical Center
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Patients MA/Cr< 30 ug/mg MA/Cr> 30 ug/mg
N 54 (71%) 22 (29%)*Age, yrs 13 + 5 12 + 4
Female/Male (n) 20/16 19/21 Body mass index (kg/m2) 24 + 3 25 + 2 Systolic BP (mmHg) 122 + 7 120 + 11
Serum Cr level (mg/dl) 0.5 + 0.2 0.6 + 0.2
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
*p=0.002
Table 1. Patients characteristics in relation to MA
Results
![Page 18: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/18.jpg)
©2007 RUSH University Medical Center
Results
MA/Cr< 30 μg/mg• Normal tissue 50%• TGBM 28% • IgA GN: 2%
MA/Cr> 30 μg/mg• IgA GN 91%• 9% TGBM 9%
Table 2. Glomerular lesion in relation to MA
![Page 19: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/19.jpg)
©2007 RUSH University Medical Center
Fig 1. MA and glomerularl lesion
IgA (n=21) TBMD (n=17) Normal (n=38)
MA
/CR
(u
g/m
g)
100
90
80
70
60
50
40
30
0
P=0.002
![Page 20: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/20.jpg)
©2007 RUSH University Medical Center
Fig 2. MA and glomerular lesion
0
10
20
30
40
50
60
70
80
90
100
IgA
TBMD
Normal
glom
erul
ar le
sion
(%
)
MA/Cr >30 MA/Cr<30
MA/Cr μg/mg
![Page 21: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/21.jpg)
©2007 RUSH University Medical Center
Conclusions
• Routine measurements of urinary MA is warranted in children with isolated persistent hematuria
• Screening for MA usually predicts a specific morphologic type of glomerular disease
• It may help to identify a subgroup of patients who are at higher risk for IgA nephropathy and could benefit early therapy and closer follow-up
![Page 22: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/22.jpg)
©2007 RUSH University Medical Center
Conclusions (cont’d)
• A renal biopsy should be considered in the child whose microscopic hematuria is associated with MA
• Children with isolated hematuria and strong family history of benign hematuria, in the absence of MA may not require a renal biopsy to confirm the diagnosis
![Page 23: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/23.jpg)
Report on the study
• Publishing your research findings
- Research is conducted for the benefit of patients,
health care providers, and the public in general
- Inform the participants of your research
• Presenting for conferences and seminars
• Assadi F. Value of urinary excretion of microalbumin in predicting glomerular lesions in children with isolated microscopic hematuria. Pediatr Nephrol 2005; 20:1131-1135
©2007 RUSH University Medical Center
![Page 24: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/24.jpg)
Turning ideas into a research question
• Association between hyperuricemia and essential hypertension among children and adolescents.
©2007 RUSH University Medical Center
![Page 25: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/25.jpg)
Turn your idea into research
• Essential hypertension (EHTN) is frequently associated with hyperuricemia in both adult and pediatric patients.
• More than 80% of children with essential HTN have serum uric acid (UA) levels above 5.5 mg/dL
• Elevated UA level is a predictor of incident HTN and cardiovascular disease.
• UA causes HTN in a rat model through the activation of the RAS, down regulation of nitric oxide, and vascular endothelial dysfunction.
![Page 26: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/26.jpg)
Hypothesis
• Treating EHTN with usual antihypertensive agents does not completely reduce cardiovascular risk related to uric acid (UA) levels.
• Lowering serum UA levels with allopurinol may provide greater benefit than simply treating HTN with the conventional therapy.
• Feig DI et al. JAMA 2008;300:924-932
![Page 27: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/27.jpg)
Purpose of the study
• To investigate the potential therapeutic effects of UA-lowering agent, allopurinol in combination with an ACE inhibitor on BP in hyperuricemic children with newly diagnosed EHTN.
![Page 28: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/28.jpg)
Design the study and methods
• Participant involvement• Study design and sampling
- What method will give the most useful data?
- What is the probability and non-probability of
sampling method?• Research methods
- Choosing qualitative and quantitative methods• Statistical issues
- Online statistics textbook from “www.Statsoft.com”• Collaboration with other researchers
©2007 RUSH University Medical Center
![Page 29: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/29.jpg)
Patients referred for the evaluation hypertension (n=118)
Excluded (n=47) • Prehypertension (n=23) • Abnormal urinalysis (n=11) • Stage 2 hypertension (n=5) • Hydronephrosis (n=4) • Cystic kidney disease (n=2) • White coat hypertension (n=1) • Pheochromocytoma (n=1)
Patients with stage 1 hypertension (n=71)
Excluded (n=19)Serum uric acid <5.5 mg/dL
Patients randomized (n=52)
Enalapril plus allopurinol (n=28)
Excluded (n=4) • poor compliance (n=4)
Excluded (n=4) • Poor compliance (n=3) • stage 2 hypertension
Completed 8 weeks study and included in analysis (n=20)
Completed 8 weeks study and included in analysis (n=24)
Enalapril (n=24)
![Page 30: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/30.jpg)
Characteristic Enalapril therapy(n=20)
Combination therapy (n=24)
P value
Gender (N) Male (12)Female (8)
Male (13)Female (11)
NSNS
Age (year) mean (range)
14.2 (12-17) 15.9 (12-19) NS
BMI (percentile)mean (range)
88 (85-99) 92 (89-93) NS
Serum UA (mg/dL) mean (range)
6.6 (6.0-7.3) 6.8 (6.2-7.1) NS
Systolic BP (mmHg)mean (range)
133 (129-136) 134 (128-137) NS
Diastolic BP (mmHg)Mean (range)
85 (82-86) 86 (80-87) NS
Baseline characteristics
![Page 31: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/31.jpg)
Parameter Enalapril therapy (n=20)
Combination therapy (n=24)
P value
Change in systolic BP (mmHg)
-4.3 (-2.1 to -6.7) -8.2 (-7.2 to -9.8) 0.001
Change in diastolic BP
-2.4 (-1.1 to -2.2) -6.3 (-1.9 to -7.8) 0.006
Serum uric acid (mg/dL)
-3.3 (-2.9 to -5.2) -5.1 (-5.8 to-6.7) 0.002
Results
![Page 32: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/32.jpg)
![Page 33: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/33.jpg)
©2007 RUSH University Medical Center
![Page 34: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/34.jpg)
Conclusions
• Allopurinol enhances the BP lowering effect of enalapril in hyperuricemic adolescents with stage-1 primary HTN by reducing serum UA level.
• Treatment regimen that lowers serum uric level may be indicated to decrease the incidence of CVD by reducing serum UA level.
• Assadi F. Allopurinol enhances the blood pressure lowering effect of enalepril in children with hyperuricemic essential hypertension. J Nephrol 27:51-56
![Page 35: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/35.jpg)
Future Direction
• Increased dietary intake of fructose, which is a known cause of hyperuricemia, may be contributing to the current epidemic of obesity and HTN.
• Ongoing clinical trials will elucidate the role of UA in human HTN and will determine whether control of UA may be a new way to prevent or treat essential HTN.
![Page 36: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/36.jpg)
©2007 RUSH University Medical Center
1.Turning your ideas into research questions
2. Review the literature
3. Design the study and develop your methods
4. Writing your research proposal
5. Obtain ethical and trust approval
6. Collect and collate the data
7. Analyze the data and interpret the findings
8. Report on the study and the findings
• Decide on an area of research• What is your aim and
hypothesis?• Where do I start?• Libraries• Links to useful websites
• Participant involvement• Study design and methods• Statistic issues• Collaboration
• Starting your research proposal• Peer review• Sponsor issues
• Why ethics are so important?• Prepare consent forms• Contact your RD office
• Issues to consider• Data protection and
confidentiality • Data analysis• Interpreting data
• Publishing your research• Future direction
Research Process Flowchart
![Page 37: How to properly plan and conduct research projects? Farahnak Assadi, MD Emeritus Professor Pediatric Nephrology](https://reader036.vdocuments.us/reader036/viewer/2022081506/56649e355503460f94b24bec/html5/thumbnails/37.jpg)
©2007 RUSH University Medical Center